Lin Health Raises $11M Series A to Expand Virtual Chronic Pain Care Platform Nationwide
Lin Health, a Denver‑based digital health company focused on transforming chronic pain care through virtual, behavioral treatment programs, has successfully closed an oversubscribed $11 million Series A funding round to accelerate growth, expand partnerships with health systems and payers, and scale its neuroscience‑driven care platform. The financing reflects strong investor confidence in Lin Health’s mission to address chronic pain, one of the most costly and widespread challenges in the U.S. healthcare system.
The Series A round was led by Proofpoint Capital, a U.S. venture firm formed by seasoned healthcare operators that focuses on backing category‑defining healthcare companies. New investors Osage Venture Partners and NewHealth Ventures joined the round, bringing fresh support to the company’s expansion plans. Existing backers also participated, including aMoon, Mayo Clinic, Saban Ventures, Shoni Health Ventures, and Viola Ventures, illustrating ongoing belief in Lin Health’s approach to chronic pain care.
Lin Health’s platform offers a virtual, physician‑led chronic pain recovery program that combines evidence‑based behavioral health strategies with high‑touch patient engagement. The company’s model blends elements of Pain Reprocessing Therapy, Emotional Awareness and Expression Therapy, and Cognitive Behavioral Therapy with coaching support to address maladaptive pain circuits at their root in the nervous system. This approach aims to deliver effective, non‑opioid care for conditions including migraines, irritable bowel syndrome, and back and joint pain.
Founded in 2021 by CEO and Co‑Founder Yehuda Kogan, Lin Health tackles a major blind spot in U.S. healthcare: chronic pain, which imposes a significant economic and human burden, costing more annually than cancer and diabetes combined. The company partners with payers and providers to integrate its digital care model into existing clinical workflows, enabling patients to receive personalized support through a combination of clinician oversight and proprietary technology designed to scale care delivery efficiently across large populations.
According to company leadership, the newly raised capital will be used to drive product innovation, strengthen clinically integrated partnerships, and expand go‑to‑market efforts nationwide. Lin Health’s AI‑enabled care platform supports a high degree of personalization and scalability while maintaining a human‑led delivery model that health professionals and patients trust. By deepening integrations with health systems and insurance providers, the company aims to make its chronic pain care solution more widely accessible to millions of Americans.
Investors in the round highlighted the unique value proposition Lin Health brings to an underserved segment of the healthcare market. Dan Goldsmith of Proofpoint Capital, who is joining Lin Health’s board of directors as part of the financing, emphasized the company’s combination of technology and clinical expertise as a transformative force in pain care. Goldsmith noted that Lin Health’s model not only delivers meaningful outcomes for patients but also addresses inefficiencies and financial pressures faced by payers and care teams.
Lin Health’s digital platform is accessible to more than 60 million Americans through partnerships with major health insurers and integrated medical practices. This breadth of coverage underscores the company’s progress in establishing itself as a scalable, first‑line solution for chronic pain management. By providing evidence‑based care that can be delivered remotely, Lin Health helps reduce reliance on traditional, often riskier treatment modalities such as long‑term opioid use or invasive procedures.
The company also continues to expand its network of clinical partners, enhancing both reach and credibility in the broader healthcare ecosystem. Lin Health reported growing demand from health systems seeking to embed its virtual care model into existing clinical pathways, a trend that aligns with broader shifts toward value‑based care and digital health adoption.
As Lin Health moves forward with its Series A funding behind it, the company is poised to broaden its impact on chronic pain care, strengthen technological capabilities, and deepen its footprint across care delivery networks. With a clear focus on expanding access and improving outcomes, Lin Health anticipates accelerating nationwide adoption of its care platform and scaling solutions that alleviate the burden of chronic pain for both patients and healthcare systems.
